SCHEMBL27821978

SCHEMBL27821978

Cn1ccnc1-c1ccc(F)cc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.41
KCNH2 Q12809 1/20 0.39
MC4R P32245 2/20 0.37
P2RX7 Q99572 1/20 0.36
HTR2C P28335 2/20 0.35
HTR2A P28223 1/20 0.35
KMT2A Q03164 1/20 0.34
HSD11B1 P28845 1/20 0.34
GRM1 Q13255 1/20 0.34
GRM4 Q14833 1/20 0.34
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
HDAC4 P56524 1/20 0.33
MAPT P10636 1/20 0.33
ATR Q13535 1/20 0.33
BDKRB2 P30411 1/20 0.33
ADRA1D P25100 1/20 0.33
ADRA1A P35348 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31039260 0.87 BRD4 (0.41) BRD4KCNH2MC4RP2RX7HTR2C
SCHEMBL31439827 0.83 BRD4 (0.43) BRD4P2RX7HTR2CHTR2AKMT2A
SCHEMBL5796145 0.83 BRD4 (0.43) BRD4P2RX7HTR2CHTR2AKMT2A
SCHEMBL14960647 0.81 HSD11B1 (0.54) BRD4MC4RP2RX7HSD11B1GRM1
SCHEMBL27470748 0.79 BRD4 (0.40) BRD4MC4RHTR2CHTR2AKDM4E
SCHEMBL31319322 0.78 MC4R (0.41) BRD4MC4RHTR2CHTR2AKMT2A
SCHEMBL19029699 0.76 BRD4 (0.53) BRD4MC4RHTR2CHTR2AKMT2A
SCHEMBL15803554 0.76 MAPK14 (0.43) BRD4MC4RP2RX7HTR2CHTR2A
SCHEMBL13878871 0.75 BRD4 (0.39) BRD4MC4RHTR2CHTR2AKDM4E
SCHEMBL13360249 0.73 MC4R (0.46) BRD4MC4RHTR2CHTR2AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102906089-A Compounds for the treatment of hepatitis C BRISTOL MYERS SQUIBB CO 2013-01-30 CN disclosed
CN-102209711-A Compounds for the treatment of hepatitis c BRISTOL MYERS SQUIBB CO 2011-10-05 CN disclosed